ALLR Allarity Therapeutics, Inc.

3d ago, source: Seeking Alpha

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response ...

Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)

9d ago, source:

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company ...

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

22d ago, source: Stockhouse

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to ...

Allarity Therapeutics Inc (ALLR) Stock: A Value Analysis

11d ago, source: newsheater

Based on Allarity Therapeutics Inc (ALLR), the company’s capital structure generated -0.9 points at debt to capital in total, while cash flow to debt ratio is standing at -9.8. The debt to equity ...

Allarity Therapeutics, Inc. (ALLR)

1d ago, source: Yahoo Finance

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer ...

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

22d ago, source: Business Insider

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer ...

Allarity Therapeutics Inc ALLR

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...